HiFiBiO Therapeutics lands $37.5 mln Series B
HiFiBiO Therapeutics, a biotherapeutics company, has raised $37.5 million in Series B funding. Sequoia China and LYFE Capital led the round with participation from VI Ventures, Nest.Bio Ventures, Legend Star Capital and Proxima Ventures.
16 May 2018•3 mins read
